Showing results (1-10 of 811) with videos related to
Sort By:
Pageof 82
Expert Opinion on Pharmacotherapy|March 24, 2010
Nebivolol in chronic heart failure: current evidence and future perspectivesErik Lipsic, Dirk J van VeldhuisenNature Reviews. Cardiology|June 29, 2011
Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MIPeter van der Meer, Dirk J van VeldhuisenInternational Journal of Cardiology|January 15, 2008
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patientsColin J Petrie, Adriaan A Voors, Dirk J van VeldhuisenCardiovascular Therapeutics|October 27, 2010
Erythropoiesis-stimulating agents and heart failureErik Lipšic, Peter van der Meer, Dirk J van VeldhuisenCurrent Heart Failure Reports|April 29, 2010
Galectin-3 in cardiac remodeling and heart failureRudolf A de Boer, Lili Yu, Dirk J van VeldhuisenClinical Science (London, England : 1979)|November 15, 2007
Erythropoietin in cardiovascular diseases: exploring new avenuesPeter van der Meer, Dirk J van Veldhuisen, James L JanuzziMicrocirculation (New York, N.Y. : 1994)|April 18, 2003
The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalitiesRudolf A De Boer, Yigal M Pinto, Dirk J Van VeldhuisenExpert Opinion on Pharmacotherapy|July 31, 2007
Nebivolol: third-generation beta-blockadeRudolf A de Boer, Adriaan A Voors, Dirk J van VeldhuisenHeart & Lung : the Journal of Critical Care|January 24, 2006
Marital status, quality of life, and clinical outcome in patients with heart failureMarie Louise Luttik, Tiny Jaarsma, Nic Veeger, et al.JACC. Heart Failure|November 13, 2017
Anemia in Heart Failure: Still Relevant?Niels Grote Beverborg, Dirk J van Veldhuisen, Peter van der MeerPageof 82